DOI:
10.1055/s-00000131
Synfacts
LinksClose Window
References
Carter PH. * et al. Bristol-Myers Squibb Company, Princeton, USA
Use of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672.
ACS Med. Chem. Lett. 2019;
10: 300-305
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.